Effect of liraglutide 3.0 mg in individuals with obesity and moderate or severe obstructive sleep apnea: the SCALE Sleep Apnea randomized clinical trial

BACKGROUND: Obesity is strongly associated with prevalence of obstructive sleep apnea (OSA), and weight loss has been shown to reduce disease severity. OBJECTIVE: To investigate whether liraglutide 3.0 mg reduces OSA severity compared with placebo using the primary end point of change in apnea–hypop...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Int J Obes (Lond)
Main Authors: Blackman, A, Foster, G D, Zammit, G, Rosenberg, R, Aronne, L, Wadden, T, Claudius, B, Jensen, C B, Mignot, E
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group 2016
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4973216/
https://ncbi.nlm.nih.gov/pubmed/27005405
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/ijo.2016.52
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados